Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Adeno Associated Virus 2
9%
Adenoviridae
27%
Blood Component
11%
Blood Plasma
15%
Bone Marrow Transplantation
9%
Chlamydia Trachomatis
9%
Conjugate
9%
Dengue Virus
14%
Enzyme Immunoassay
9%
Flavivirus
12%
HBV DNA
9%
Hepatitis
49%
Hepatitis B
20%
Hepatitis B Core Antibody
9%
Hepatitis B Virus
14%
Hepatitis C Virus
20%
Hepatitis E
20%
Hepatitis E Virus
43%
Hepatitis Virus
10%
Human Herpesvirus 8
9%
Human Immunodeficiency Virus
26%
Human Immunodeficiency Virus 1
23%
Infection
100%
Infection after Stem Cell Transplantation
9%
Infectious Disease
90%
Intravenous Immunoglobulin
9%
Neutralization
9%
Nucleic Acid Amplification
9%
Omicron Coronavirus Variant
9%
Pig
13%
Plasmid
9%
Polymerase Chain Reaction
18%
Prevalence
20%
Protease
9%
Proteinase
9%
Ribavirin
10%
Ribonucleic Acid
12%
Serology
11%
Serotype
11%
Severe Acute Respiratory Syndrome Coronavirus 2
31%
Stem Cell
9%
Usutu Virus
9%
Viral Disease
47%
Viral Hepatitis
9%
Viral Load
33%
Virology
9%
Virus
32%
Virus Antibody
9%
West Nile Virus
9%
Zika Virus
28%
Keyphrases
95% Confidence Interval
13%
Acquired Infection
11%
Adenovirus
12%
Adenovirus Infection
19%
Antiretroviral Therapy
14%
Blood Components
19%
Blood Donation
11%
Blood Donors
18%
Blood Safety
15%
Blood Supply
13%
Blood-borne Viral Infections
14%
Chlamydia
19%
Clinical Management
11%
COBAS TaqMan
16%
COVID-19
19%
Deceased Donor
22%
Disease Transmission
11%
European Union
19%
Genotype 3
14%
Healthcare
12%
Hepatitis B Virus
18%
Hepatitis C
11%
Hepatitis C Virus
15%
Hepatitis E
28%
Hepatitis E Virus
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
31%
Illness
13%
India
11%
Infection Risk
17%
Infectious Diseases
11%
Nucleic Acids
19%
Performance Evaluation
19%
Point-of-care
35%
Polymerase Chain Reaction
15%
Rapid Test
16%
Resource-limited Settings
19%
Ribavirin
11%
Serology
16%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
12%
Solid Organ Transplant
19%
Solid Organ Transplant Recipients
28%
Solid Organ Transplantation
15%
South East England
19%
Transfusion Threshold
14%
Transplant Recipients
19%
United Kingdom
28%
Viral Load
14%
Virus
23%
Zika
13%
Zika Virus
15%
Medicine and Dentistry
Acute Hepatitis
9%
Adenoviridae
13%
Adenovirus Infection
19%
Antiretroviral Therapy
11%
Blood Component
9%
Bone Marrow Transplantation
9%
Case-Control Study
9%
Chlamydia Infection
7%
Chlamydia Rapid Test
19%
Chlamydiae
13%
Clinical Management
12%
Cohort Analysis
9%
Corneal Transplantation
9%
COVID-19
20%
Deceased Donors
10%
Diseases
14%
Etiology
9%
Evaluation Study
9%
Health Care Personnel
14%
Hepatitis
15%
Hepatitis E Virus
19%
High Risk Behavior
9%
Horizontal Disease Transmission
15%
Human Herpesvirus 8
9%
Human Immunodeficiency Virus
21%
Human Immunodeficiency Virus 1
9%
Human Parainfluenza Virus 3
9%
Idiopathic Thrombocytopenic Purpura
9%
Immunosuppressive Treatment
7%
Infection
46%
Infection after Stem Cell Transplantation
9%
Kaposi Sarcoma
7%
Kidney Transplantation
9%
Liver Transplantation
11%
Molecular Epidemiology
9%
Morbidity
9%
Nucleic Acid
9%
Organ Donor
31%
Pediatrics
19%
Polymerase Chain Reaction
21%
Prevalence
11%
Prospective Cohort Study
9%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Solid Organ Transplantation
15%
Strongyloidiasis
9%
Thrombosis
9%
Urinalysis
9%
Virus
16%
Virus Infection
13%
Visceral Leishmaniasis
9%